Summary of Statement of Operations Acquisition (Details) - USD ($) |
3 Months Ended | 6 Months Ended | 12 Months Ended | |||||
|---|---|---|---|---|---|---|---|---|
Dec. 31, 2021 |
Sep. 30, 2021 |
Dec. 31, 2020 |
Sep. 30, 2020 |
Dec. 31, 2021 |
Dec. 31, 2020 |
Jun. 30, 2021 |
Jun. 30, 2020 |
|
| Business Acquisition [Line Items] | ||||||||
| Net Revenues | $ 245,991 | |||||||
| General and Administrative expenses | 699,830 | 5,505 | 507,768 | 17,913 | ||||
| Depreciation and amortization | 97,511 | |||||||
| Total Operating Expenses | 934,988 | 7,670 | 507,768 | 17,913 | ||||
| Loss from Operations | (688,997) | (7,670) | (507,768) | (17,913) | ||||
| Other (Expense) | 99,974 | |||||||
| Net Loss | $ (292,663) | $ (296,360) | $ (3,260) | $ (4,410) | $ (589,023) | $ (7,670) | $ (507,768) | $ (17,913) |
| Basic and Diluted (loss) per share | $ (0.00) | $ (0.00) | $ (0.00) | $ (0.00) | ||||
| Basic and Diluted weighted average common shares outstanding | 234,953,286 | 249,418,545 | 249,220,391 | 249,418,545 | ||||
| Rennova Health Inc [Member] | ||||||||
| Business Acquisition [Line Items] | ||||||||
| Net Revenues | $ 266,446 | $ 493,621 | ||||||
| Direct costs of revenues | 7,166 | |||||||
| General and Administrative expenses | 794,262 | 1,343,436 | ||||||
| Depreciation and amortization | 96,800 | 195,055 | ||||||
| Total Operating Expenses | 891,062 | 1,545,657 | ||||||
| Loss from Operations | (624,616) | (1,052,036) | ||||||
| Other (Expense) | (62,703) | (42,103) | ||||||
| Net Loss | $ (687,319) | (1,094,139) | ||||||
| Net loss attributed to common stockholders | $ (1,861,639) | |||||||
| Basic and Diluted (loss) per share | $ (0.00) | $ (0.00) | ||||||
| Basic and Diluted weighted average common shares outstanding | 234,953,286 | 234,953,286 | ||||||
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Definition The aggregate cost of goods produced and sold and services rendered during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. No definition available.
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS). No definition available.
|
| X | ||||||||||
- Details
|